Alexandria Co. For Pharmaceuticals & Chemical Industries

E£1,330As of Sun 8 Nov 2026, 12:00 UTC
EGX:AXPHHealthcare
Country Egypt
PE (Fwd) •••
TSR 10Y CAGR 51.09%
Div yield 4.74%
ROE 48.29%
Pharmaceutical Preparations
Beta (5Y) 0.16
PE TTM 14.31
TSR TTM 61.72%
Mkt cap E£6.649B
ROIC 70.60%
SE Grade™
Value
Quality
Moat
Consensus
Reference
E£1,293
(2.76%)
(93.06%)
Hold 12|6|6|11|1
2Q26
3Q26
4Q26
1Q27
Earnings per shareE£
26.52
25.39
28.36
30.24
45.70%
24.86%
31.99%
26.93%
RevenueE£M
382.7
390.2
387.9
386.3
5.93%
3.25%
3.78%
4.76%
Peers (US$124.0M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.931
(0.011)
(0.011)
EBIT/Intx
0.506
0.125
0.107
Own earn%
47.29
(69.36)
(36.35)
Sh yield%
20.21
27.57
27.71
Owners
Insiders/Inst%
13.30
56.52
Short interest%
3.97
SBC / revenue%
4.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
30–35
$1 testx
—
Incr. ROIC%
41